DOXOrubicin
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93723 publications
[Expression of Concern] Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
Journal: Oncology letters
Published: September 08, 2026
Aggressive B-cell lymphomas with MYC gene cluster amplification: a clinicopathological analysis of eight cases
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: September 07, 2026
Corrigendum to: Cardioprotective Potential of Moringa oleifera Leaf Extract Loaded Niosomes Nanoparticles - Against Doxorubicin Toxicity in Rats.
Journal: Current pharmaceutical biotechnology
Published: September 07, 2026
Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy.
Journal: Journal of drug targeting
Published: September 05, 2026
Mitochondrial superoxide-induced mitohormesis is mediated by citrate and cardioprotective.
Journal: Science advances
Published: September 04, 2026
Size-dependent surface engineering of magnetic micro/nanorobots for synergistic chemo-magnetothermal cancer therapy.
Journal: Chemical communications (Cambridge, England)
Published: September 02, 2026
Unmasking a Hidden Burden: Chemotherapy-Induced and Exacerbated Diabetes in Paediatric Cancer: A Report of Two Cases.
Journal: Nigerian medical journal : journal of the Nigeria Medical Association
Published: September 01, 2026
Corrigendum to "Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles" [Arch. Biochem. Biophys. 671, (2019), 143-151].
Journal: Archives of biochemistry and biophysics
Published: August 30, 2026
Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.
Journal: Leukemia & lymphoma
Published: August 30, 2026
Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: August 30, 2026
Last Updated: 09/19/2026